Keyphrases
Phase II Study
100%
Patients with Hypertension
100%
Randomized Double-blind
100%
Amlodipine
100%
Antihypertensive Combination Therapy
100%
Losartan
77%
Dose Combination
44%
Third Dose
44%
Half-dose
44%
Response Rate
33%
Triple Combination
33%
Chlorthalidone
33%
Systolic Blood Pressure Reduction
33%
Placebo Groups
22%
Treatment Group
11%
Hypertension
11%
Placebo
11%
Ankle
11%
Moderate to Severe
11%
Combination Treatment
11%
Systolic Blood Pressure
11%
Intergroup Difference
11%
Trial Registration
11%
Mg Treatment
11%
Drug Adverse Events
11%
Placebo Run-in
11%
Control Rate
11%
Triple Therapy
11%
BP Control
11%
Antihypertensive Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Antihypertensive Agent
100%
Amlodipine
100%
Losartan
77%
Placebo
44%
Chlortalidone
33%
Adverse Event
11%
Antihypertensive Therapy
11%
Dipin
11%